Adverse effect versus quality control of the Fuenzalida-Palacios antirabies vaccine

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 40, Issue 5, 1998, Pages 295-299

  Nogueira, Yeda L ^a,b  

^a Pesquisadora Cie Inst Adolfo L   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Adverse effect; Albumin; Antirabies vaccine; Crossed immunoelectrophoresis; Fuenzalida Palacios; HDVC

Indexed keywords

MYELIN; RABIES VACCINE;

ARTICLE; DRUG PURITY; GUILLAIN BARRE SYNDROME; IMMUNIZATION; IMMUNOELECTROPHORESIS; PARALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; QUALITY CONTROL; RISK FACTOR;

EID: 0032445832     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651998000500006     Document Type: Article

References (20)

1. ANDERSON, M.C.; BAER, H.; FRAZIER, D.J. & QUINNAN. G.V. - The role of specific IgE and ß-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine. J. Allergy clin. Immunol., 80: 861-868, 1987.
2. ARNASON, B.G. - Inflammatory polyradiculoneuropathies. In: DYCK, E.P.J; THOMAS, P.K. & LAMBERT, E.H. Peripheral neuropathy. Philadelphia, W.B. Saunders, 1975. p.1110.
3. BOE, E. & NYLAND, H. - Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine. Scand. J. infect. Dis., 12: 231-232, 1980.
4. BRADFORD, M.M. - A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem.,72: 248-254, 1976.
5. CLARKE, H.G. & FREEMAN, T. - A quantitative immuno-electrophoresis method (Laurell electrophoresis). In: PECTERS, H., ed. Protein and biological fluids. Amsterdam, Elsevier, 1967. p.503-509.
6. COSTA, W.A. - Eventos adversos da vacina contra raiva humana. (Communication to: SIMPÓSIO ANUAL DE IMUNIZAÇÃO DO ESTADO DE SĀO PAULO, 1, São Paulo, 1997).
7. FUENZALIDA, E. & PALACIOS, R. - Un método mejorado en la preparación de la vacuna antirábica. Bol. Inst. bact. Chile, 8: 3-9, 1955.
8. FUNDAÇĀO NACIONAL DE SAÚDE .http://www.datasus.gov.br
9. GARNER, W.R.; JONES D.O. & PRATT, E. - Problems associated with rabies preexposure prophylaxis. J. Amer. med. Ass., 235: 1131-1132, 1976.
10. LAEMMLI, U.K. - Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-681, 1970.
11. LAURELL, C.B. - Antigen-antibody electrophoresis. Analyt. Biochem., 5: 358-366, 1966.
12. LEMOS, H.N. & SOUZA, M.M. - Reaçōes adversas na vacinação anti-rábica humana. Folha méd., 101: 299-303, 1990.
13. NOGUEIRA, Y.L. & MONTAN̄O, J. A. - Imunoeletroforese bidimensional como método para identificaçāo de fraçōes imunogênicas da vacina anti-rábica tipo Fuenzalida-Palacios, e seu possível uso para o diagnóstico e prevençāo de acidentes neuroparalíticos pós-vacinais. Arq. Biol. Tecnol., 28: 297-306, 1985.
14. NOGUEIRA, Y.L - Rabies virus in McCoy cell line. Part III. (Purification). Rev. Inst. Adolfo Lutz, 56: 19-26, 1996.
15. SIKES, K.R. & LARGHI, O.P. - Purification of rabies virus. Immunology, 99: 545-553, 1967.
16. SOUZA, M.M. - Estudo imunológico da raiva. Rio de Janeiro, 1976. (Dissertação de Mestrado - Instituto de Microbiologia da Universidade Federal do Rio de Janeiro).
17. TYRELL, D. - Vaccination against rabies. Trans. roy. Soc. trop. Med. Hyg., 70: 202-205, 1976.
18. WARRINGTON, R.J.; MARTENS, C.J.; RUBIN, M.; RUTHERFORD, W.J. & AOKI, F.Y. - Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine. J. Allergy clin. Immunol., 79: 605-610, 1987.
19. WEEKE, B. - The serum proteins identified by means of Laurell crossed electrophoresis. Scand. J. clin. Lab. Invest., 25: 269-275, 1970.
20. WIKTOR, T.J.; FERNANDES, M. V. & KOPROWISKI, H.-Cultivation of rabies virus in human diploid cell rabies strain WI-38. J. Immunol., 93: 553-566, 1964.